Adlyfe Study on the Detection of Misfolded Proteins Published in the Journal T... ( Misfolded Protein Diagnostic (MPD)...)

Adlyfe Study on the Detection of Misfolded Proteins Published in the Journal Transfusion

Date:8/29/2007

Misfolded Protein Diagnostic (MPD) Shown to be Sensitive and Specific Technology Applicable for the Detection of a Host of Amyloid Neurological

Diseases including Creutzfeldt-Jakob Disease (CJD), Alzheimer's, and

Parkinson Disease

ROCKVILLE, Md., Aug. 29 /PRNewswire/ -- Adlyfe, a private company developing novel diagnostic testing technologies for early targets of amyloid diseases, announced today the publication of a study, "Detection of misfolded prion protein in blood with conformationally sensitive peptides," in the August 2007 issue of the journal Transfusion. The monthly publication is the official peer-reviewed journal of the AABB, formerly known as the American Association of Blood Banks.

The published study examined the ability of Adlyfe's Misfolded Protein Diagnostic (MPD) to detect the presence of misfolded proteins in brain, serum and plasma. Study results demonstrated that Adlyfe's MPD assay is a sensitive and specific test for the detection misfolded prion proteins that may be useful in both preclinical and clinical diagnosis transmissible spongiform encephalopathy (TSE) diseases in both animals and humans.

Scientists have tried to develop a preclinical diagnostic test for TSE since the discovery that humans with variant Creutzfeldt-Jakob disease can transmit disease via blood transfusions, though there are several challenges to detecting misfolded proteins in the blood. The coexistence of a large amount of the protein in its normally folded shape and the fact that misfolded proteins do not trigger an immune system response that would enable diagnosis based on the detection of antibodies. In addition, most standard detection methods are not sensitive enough to detect the low level of misfolded proteins in the blood, especially during early disease stages. These challenges have largely restricted diagnostic tests for amyloid diseases to the use of postmortem tissue.

Adlyfe's novel tech
'/>"/>

SOURCE Adlyfe
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea

Post Your Comments:

(Date:12/14/2009)... Calif., Dec. 14 The Roberts ... today released the analysis of social responsibility ... world-wide. The report contains a compilation of ... environmental and social reporting of the companies. ... and performance for both environmental and social ...

(Date:12/14/2009)... 14 According to Millennium Research ... technology market intelligence, Japan,s complex regulatory environment ... a significant lag in peripheral vascular stenting ... other developed nations. MRG,s new ... report finds, however, that recent indication-specific ...

(Date:12/14/2009)... INDIANAPOLIS, Dec. 14 The ... RELPREVV (olanzapine) For Extended Release Injectable Suspension for ... and Company (NYSE: LLY ) announced ... the delivery of olanzapine for up to four ... short-acting formulations, long-acting formulations of antipsychotics allow for ...

Breaking Medicine Technology:New Report Grades Sustainability Reporting of Top Pharmaceutical Companies 2 New Report Grades Sustainability Reporting of Top Pharmaceutical Companies 3 Japanese Peripheral Vascular Stent Procedures to Experience 11% Growth Through 2014 2 Japanese Peripheral Vascular Stent Procedures to Experience 11% Growth Through 2014 3 FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 2 FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 3 FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 4 FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 5 FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 6 FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 7 FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 8 Endo Pharmaceuticals Gives Update on Regulatory Status of Testosterone Undecanoate for Men with Hypogonadism 56079 1 Endo Pharmaceuticals Gives Update on Regulatory Status of Testosterone Undecanoate for Men with Hypogonadism 56079 2 Endo Pharmaceuticals Gives Update on Regulatory Status of Testosterone Undecanoate for Men with Hypogonadism 56079 3 Endo Pharmaceuticals Gives Update on Regulatory Status of Testosterone Undecanoate for Men with Hypogonadism 56079 4 Healthcare Debate 3A One Citizens Call for Calm Catches On 56077 1 Healthcare Debate 3A One Citizens Call for Calm Catches On 56077 2 Connecticut Cigarette Tax Increase Delivers Victory for Kids and Taxpayers 3B 241 Increase Gives State Second Highest Cigarette Tax in the Nation 56075 1 Connecticut Cigarette Tax Increase Delivers Victory for Kids and Taxpayers 3B 241 Increase Gives State Second Highest Cigarette Tax in the Nation 56075 2 Connecticut Cigarette Tax Increase Delivers Victory for Kids and Taxpayers 3B 241 Increase Gives State Second Highest Cigarette Tax in the Nation 56075 3

[0] New Report Grades Sustainability Reporting of Top Pharmaceutical Companies [0] Japanese Peripheral Vascular Stent Procedures to Experience 11% Growth Through 2014 [0] FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults

... 8, 2007 - Hollis-Eden,Pharmaceuticals, Inc. (NASDAQ:HEPH) today ... 07, 2007, by the Department of,Health & ... candidate for the treatment of Acute Radiation ... no longer in the,competitive range for the ...

... TRIANGLE PARK, N.C., Mar 8, 2007 (CCNMatthews ... (TSX:AHX)(AMEX:ADH), a,biopharmaceutical company with a broad portfolio ... Dr. Antonella,Perotti, MD, Istituto Nazionale dei Tumori ... Phase Ib/II study,of single-agent ADH-1, will present ...

Other Medicine Technology:Hollis-Eden Announces Cancellation of Acute Radiation Syndrome RFP,by Department of Health and Human Services 2 Hollis-Eden Announces Cancellation of Acute Radiation Syndrome RFP,by Department of Health and Human Services 3 Hollis-Eden Announces Cancellation of Acute Radiation Syndrome RFP,by Department of Health and Human Services 4 Hollis-Eden Announces Cancellation of Acute Radiation Syndrome RFP,by Department of Health and Human Services 5 Data From Adherex's European Phase Ib/II Trial of ADH-1 to be,Presented at International Symposium on Targeted Anticancer,Therapies 2 Data From Adherex's European Phase Ib/II Trial of ADH-1 to be,Presented at International Symposium on Targeted Anticancer,Therapies 3

Hollis-Eden Announces Cancellation of Acute Radiation Syndrome RFP,by Department of Health and Human Services Data From Adherex's European Phase Ib/II Trial of ADH-1 to be,Presented at International Symposium on Targeted Anticancer,Therapies

(Date:12/14/2009)... Regents will be asked to approve naming the women,s ... and Women,s Hospital complex -- after Ted and Jane ... The University of Michigan Health System has ... Jane Von Voigtlander Foundation, the largest gift ever made ... support the construction of a new women,s hospital. ,, ...

(Date:12/14/2009)... urban teenage girls may acquire at least one of ... of becoming sexually active, according to an Indiana University ... The study appears in the December 2009 issue of ... The researchers followed 381 girls enrolled at ages 14 ... the organisms that cause chlamydia, gonorrhea and trichomoniasis also ...

(Date:12/14/2009)... Researchers from Thomas Jefferson University are one step closer ... , Led by Matthias J. Schnell, Ph.D., director of ... rabies virusbased vaccine administered to monkeys protected against the ... were published in the journal Vaccine . , ... HIV and SIV antigens protective against a chimeric HIV/SIV ...

(Date:12/14/2009)... may be long-term solution, researchers say , , MONDAY, ... experience shoulder dislocations can benefit from a procedure ... cartilage from cadavers, new research suggests. , ... the American Journal of Sports Medicine , ... to methods that stabilize or reconstruct a shoulder ...

(Date:12/14/2009)... protective garments online to military and government personnel through DOD ... ... December 14, 2009 -- Miller,s Precision Enterprises, Inc. (MPE), leading ... recent approval as a vendor on the Department of Defense ... MPE can provide military, government and Civil Agency personnel with ...

Breaking Medicine News(10 mins):Health News:University of Michigan Health System Receives $15 Million Gift, The Largest Ever for Women's Health 2 Health News:University of Michigan Health System Receives $15 Million Gift, The Largest Ever for Women's Health 3 Health News:University of Michigan Health System Receives $15 Million Gift, The Largest Ever for Women's Health 4 Health News:University of Michigan Health System Receives $15 Million Gift, The Largest Ever for Women's Health 5 Health News:IU study: Half of urban teen girls acquire STIs within 2 years of first sexual activity 2 Health News:MPE Inc., a Leading Supplier of Recycled Protective Garments, Becomes Approved Vendor on DOD EMALL 2

[0] University of Michigan Health System Receives $15 Million Gift, The Largest Ever for Women's Health [0] IU study: Half of urban teen girls acquire STIs within 2 years of first sexual activity [0] Research reveals further progress toward AIDS vaccine [0] Shoulder Repair Technique Borrows From Cadavers [0] MPE Inc., a Leading Supplier of Recycled Protective Garments, Becomes Approved Vendor on DOD EMALL

... The Foundation,for Taxpayer and Consumer Rights (FTCR) said today ... on what hospitals will pay in,fees for access to ... Yesterday, FTCR sent a letter to legislative leaders ... any limits placed on how much,individuals and employees will ...

... 6 The University of,Texas at Austin,s Center ... "Length of Prescription Drug Payment Times by Medicare,Part ... slow,reimbursement pharmacies have endured with Medicare Part D ... the Senate and House to,pass S.1954, the Pharmacy ...

... CLEVELAND, Sept. 6 Cleveland Clinic Press,( ... ( http://www.clevelandclinic.org/ ), has just released "Write ... Journal Writing" by Dr.,Sheppard B. Kominars ( ... powerful insights and techniques for personal transformation ...

... N.J., Sept. 6 Par,Pharmaceutical Companies, Inc. (NYSE: ... Commission its 2006 Annual Report on Form 10-K. The,filing ... due to the work,involved in restating its consolidated financial ... year. Par intends to file its,Form 10-Q for the ...

... Responding to increasing,needs of children and parents, as ... it,serves, Regional Center of Orange County (RCOC) has ... it provides to families,struggling to raise children with ... launched a program to ensure that,parents having difficulty ...

... the patient real benefit, too , THURSDAY, Sept. 6 ... disease report better physical health if they participate in ... the health of spouse caregivers through counseling and support ... who are in poor health are more likely to ...

Hospitals Agree to Pay Fees in Exchange for More Income, but Consumers in the Dark About What They'll be Charged Under Nunez Plan University of Texas Study Details Lengthy Payment Delays for Medicare Part D Prescription Drug Claims, Confirming Need for Legislative Fix Cleveland Clinic Press Releases Journal-Writing Book 'Write for Life: Healing Body, Mind, and Spirit Through Journal Writing' by Sheppard B. Kominars, Ph.D.Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts' Meeting September 28, 2007 Regional Center of Orange County Expands Family Support Resources to Meet Growing Needs Counseling Boosts Alzheimer's Caregivers' Health

... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...

... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...

... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...

Medicine Products:

Flexeril FK506 Fiorinal Fibronectin Aggregates IgA, ELISA

Adlyfe Study on the Detection of Misfolded Proteins Published in the Journal T...( Misfolded Protein Diagnostic (MPD)...),Health